Marshall Wace’s Immunovant IMVT Stock Holding History

Marshall Wace’s Portfolio IMVT Stock Details IMVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.11M	Buy	+165,300	New	+$4.28M	﹤0.01%	1396
2025 Q4	–	Sell	-419,680	Closed	-$6.77M	–	3186
2025 Q3	$6.77M	Buy	+419,680	New	+$6.79M	0.01%	1073
2025 Q2	–	Sell	-138,477	Closed	-$2.37M	–	2915
2025 Q1	$2.37M	Buy	+138,477	New	+$2.9M	﹤0.01%	1400
2024 Q4	–	Sell	-114,104	Closed	-$3.25M	–	2777
2024 Q3	$3.25M	Buy	+114,104	New	+$3.37M	﹤0.01%	1170
2024 Q2	–	Sell	-53,533	Closed	-$1.73M	–	2725
2024 Q1	$1.73M	Buy	+53,533	New	+$1.95M	﹤0.01%	1429
2023 Q4	–	Sell	-5,900	Closed	-$227K	–	2370
2023 Q3	$227K	Buy	+5,900	New	+$133K	﹤0.01%	1954
2023 Q1	–	Sell	-38,953	Closed	-$691K	–	2869
2022 Q4	$691K	Buy	+38,953	New	+$490K	﹤0.01%	2242
2022 Q1	–	Sell	-8,316	Closed	-$71K	–	3644
2021 Q4	$71K	Sell	8,316 -64,506	-89%	-$533K	﹤0.01%	3471
2021 Q3	$633K	Buy	72,822 +55,655	+324%	+$502K	﹤0.01%	2280
2021 Q2	$181K	Sell	17,167 -4,027	-19%	-$56.2K	﹤0.01%	2465
2021 Q1	$340K	Buy	21,194 +15,739	+289%	+$415K	﹤0.01%	2085
2020 Q4	$252K	Buy	+5,455	New	+$252K	﹤0.01%	1696
2020 Q3	–	Sell	-63,511	Closed	-$1.55M	–	1742
2020 Q2	$1.55M	Buy	63,511 +52,475	+475%	+$1.12M	0.01%	877
2020 Q1	$172K	Buy	+11,036	New	+$166K	﹤0.01%	1207

Other funds holding IMVT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Marshall Wace's IMVT Position: Q1 2026 in Review

Marshall Wace opened a new position in Immunovant (IMVT) in Q1 2026: 165,300 shares worth $4.11M. The stake represents ﹤0.01% of the portfolio and ranks #1396 among its holdings. This is a return to the name: Marshall Wace previously reported a position in IMVT as recently as Q3 2025.

Marshall Wace first reported a position in IMVT in Q1 2020 and has held it in 14 quarters since. The position peaked at $6.77M in Q3 2025. 215 funds tracked by Wall St. Rank hold IMVT as of Q1 2026.

Marshall Wace held 165,300 shares of Immunovant worth $4.11M as of Q1 2026.
Immunovant was a new Marshall Wace position in Q1 2026.
Immunovant made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #1396 holding.
Marshall Wace first reported a position in Immunovant in Q1 2020 and has held it in 14 quarters since.
Marshall Wace's Immunovant position peaked at $6.77M in Q3 2025.
215 funds tracked by Wall St. Rank held Immunovant as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.